Ramon, Musliha S.

HRN: 24-32-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2024
AMPICILLIN 250MG (VIAL)
03/19/2024
03/25/2024
IV
165mg
Q12
MAS
Waiting Final Action 
03/19/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/19/2024
03/25/2024
IV
50mg
OD
MAS
Waiting Final Action 
03/19/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
03/19/2024
03/19/2024
TOPICAL
-
OD
Crede’s Prophylaxis
Waiting Final Action 
05/21/2024
AMPICILLIN 500MG (VIAL)
05/21/2024
05/27/2024
IVT
200mg
Q6
UTI
Waiting Final Action 
05/23/2024
AMOXICILLIN 100MG/ML, 10ML DROPS (BOT)
05/23/2024
05/29/2024
PO
1.5mL
TID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: